GL1X · GenesisL1 explorer

MolNFT v1 · #103950 · protein

Crystal structure of the sulfite dehydrogenase sort from sinorhizobium meliloti

4PW3 · Putative sulfite oxidase: “Crystal structure of the sulfite dehydrogenase sort from sinorhizobium meliloti”. X-ray diffraction, 1 ligand (MSS), 20 pockets (best druggability 0.76). MolNFT v1 #103950 on GenesisL1: 3D structure…

PDB
4PW3
Type
protein
Length
1,458 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Putative sulfite oxidase
EC
1.8.3.1
UniProt
Q92M24
Ligands
MSS
Pockets
20 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 13% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, DPutative sulfite oxidase (EC 1.8.3.1)protein36513% helix, 36% strandQ92M24
BPutative sulfite oxidase (EC 1.8.3.1)protein36313% helix, 36% strandQ92M24

Ligands and binding sites

  • MSS · (molybdopterin-S,S)-oxo-molybdenum · ligand · 4 copies · chains A, B, C, D
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1750.760.9923MSS
2820.760.9822MSS
3750.730.9722MSS
410230.730.7691empty
5700.720.9722MSS

Interfaces

4 interfaces between chains.

  • C–D · 1322 Ų buried · 25 hydrogen bonds · protein-protein
  • A–B · 1316 Ų buried · 23 hydrogen bonds · protein-protein
  • A–D · 228 Ų buried · 0 hydrogen bonds · protein-protein
  • B–D · 31 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4PW3 · Crystal structure of the sulfite dehydrogenase SorT from Sinorhizobium meliloti · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.